The importance of effective nutritional care in patients with cancer is becoming better recognized, with a growing body of evidence demonstrating the benefits of medical nutrition solutions in optimizing health and therapeutic outcomes. So how do we better integrate new science on targeted nutritional management into standard drug therapies for patients with cancer?
Unlock exclusive insights from the DSM-hosted breakfast panel discussion held at the World Economic Forum Annual Meeting 2022 in Davos, Switzerland.
The session was hosted by Patricia Malarkey, Chief Innovation Officer and member of the Executive Committee at DSM, and brought together leading industry experts from across the field:
Senior Researcher in the Health Economics and Health Technology Assessment Area, SDA Bocconi School of Management, Milan, Italy
MD, Associate Professor of Internal Medicine, Department of Clinical Medicine, Sapienza University, Rome, Italy
Business Executive Officer, Nestlé Health Science, Switzerland and President Swiss Medical Nutrition Industry (SMNI)
Senior Scientific Affairs Manager, Global Pharmaceutics and Medical Nutrition, DSM